Addressing Stigma in Screening and Diagnostic Delay for Cervical Cancer

Brief Summary

Official Title: “Addressing Stigma in Screening and Diagnostic Delay for Cervical Cancer”

This study aims to 1) implement a culturally and contextually rooted innovative multifoci, social marketing intervention involving societal focused media campaign elements to break down the barriers and facilitate timely and appropriate screening practices for cervical cancer; 2) measure cervical cancer stigma from a culturally relevant theoretical and conceptual framework; and 3) assess the influence of stigma on hindering seeking the PAP test. Further, this is an international study that will bring together a multi-disciplinary investigatory team, community advocates and State health agencies to deliver a social marketing intervention in Southern California (the Inland Empire region specifically) and Trinidad and Tobago.

  • Study Type: Observational
  • Study Design: Observational Model: Cohort, Time Perspective: Prospective
  • Study Primary Completion Date: October 2012

Arms, Groups and Cohorts in this Clinical Trial

  • Social media intervention
    • Women between the ages of 18-70 who have not been diagnosed with any type of cancer and are of African descent or Latina

Outcome Measures for this Clinical Trial

Primary Measures

  • Evaluation of the ability of the social media intervention “End Stigma End Fear, End Cervical Cancer” to counter stigma of cervical cancer among disadvantaged women who acknowledge needing a Pap test at pre-intervention baseline
    • Time Frame: 3 months after the intervention is implemented
      Safety Issue?: No

Secondary Measures

  • Assessment of whether change in stigma score is associated with Pap testing.
    • Time Frame: 3 months after the intervention is implemented
      Safety Issue?: No
  • Identification of factors associated with exposure to the intervention overall and to its individual components
    • Time Frame: 3 months after the intervention is implemented
      Safety Issue?: No
  • Assessment of whether each component of the intervention is associated with the study endpoints, by testing the 4 components (billboards/posters, newspaper advertisements, health brochures, and radio announcements) rather than the overall exposure score
    • Time Frame: 3 months after the intervention is implemented
      Safety Issue?: No

Criteria for Participation in this Clinical Trial

Inclusion Criteria

Women will be included if they:

1. have not been diagnosed with any type of cancer

2. are between the ages of 18-70

3. self-identify as being African descended or Latina

4. are able to speak English and/or Spanish

5. acknowledge that a Pap test is currently needed

Exclusion Criteria

1. Cervical cancer is diagnosed only in women, therefore this study only includes women

2. Women who have been and/or are currently diagnosed with any type of cancer will be excluded

3. Women with other major medical conditions (e.g. stroke and degenerative illness) will be excluded

4. During the screening the level of symptomatology for depression and anxiety will be assessed. Women with severe depression and anxiety will be excluded, but appropriate psychological follow-up and referral will be provided

5. Women older than 70 years will be excluded

Gender Eligibility for this Clinical Trial: Female

Minimum Age for this Clinical Trial: 18 Years

Maximum Age for this Clinical Trial: 70 Years

Are Healthy Volunteers Accepted for this Clinical Trial: Accepts Healthy Volunteers

Clinical Trial Investigator Information

  • Lead Sponsor
    • City of Hope Medical Center
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Kimlin Ashing-Giwa, PhD, Principal Investigator, City of Hope Medical Center

Source

Clinical Trials content is provided directly by the US National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of information about a specific clinical trial contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is:
http://clinicaltrialsfeeds.org/clinical-trials/show/NCT01287871